epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
Apitegromab
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Hemiclor

chlorthalidone

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  TAB: 12.5 mg

Special Note

[equivalency or interchangeability info]
Info: not interchangeable with Thalitone; do not substitute on a mg to mg basis

HTN

[12.5-25 mg PO qam]
Info: give with food

renal dosing

[see below]
renal impairment: not defined, caution advised; anuria: contraindicated
HD/PD: not defined

hepatic dosing

[see below]
hepatic impairment/progressive hepatic disease: not defined, caution advised

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@7179dadd
  • hypersensitivity to drug or ingredient
  • anuria
  • avoid: sun exposure
  • avoid: UV light exposure, artificial
  • caution: hypersensitivity to sulfonamides
  • caution: renal impairment
  • caution: hepatic impairment
  • caution: hepatic disease, progressive
  • caution: electrolyte abnormalities
  • caution: volume depletion
  • caution: seizure disorder
  • caution: arrhythmia
  • caution: post-sympathectomy
  • caution: diabetes mellitus
  • caution: SLE
  • caution: gout history
  • caution: pancreatitis history
  • caution: HTN, gestational
  • caution: elderly patients

Drug Interactions .

Overview

chlorthalidone

thiazide diuretic

Interaction Characteristics:
  • antihypertensive agent
  • binds to anion exchange resin/polymer
  • decreases renal perfusion/fxn
  • diuretic
  • hypercalcemia
  • hyperglycemic effects
  • hyperuricemic effects
  • hypokalemia
  • hypomagnesemia
  • hyponatremia
  • photosensitivity
  • urine alkalinizer

Contraindicated

  • isocarboxazid
  • Hemiclor (chlorthalidone)
    +
    isocarboxazid
    1 interaction

    Contraindicated

    chlorthalidone + isocarboxazid

    contraindicated: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methenamine
  • Hemiclor (chlorthalidone)
    +
    methenamine
    1 interaction

    Contraindicated

    chlorthalidone + methenamine

    contraindicated: combo may decr. methenamine efficacy; may incr. risk of crystalluria (decreased conversion of methenamine to formaldehyde in alkaline urine; sulfonamides may precipitate with formaldehyde)

Avoid/Use Alternative

  • aldesleukin
  • Hemiclor (chlorthalidone)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, renal impairment (additive effects)

  • amikacin
  • Hemiclor (chlorthalidone)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + amikacin

    use alternative or monitor amikacin levels, renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • aminolevulinic acid topical
  • Hemiclor (chlorthalidone)
    +
    aminolevulinic acid topical
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + aminolevulinic acid topical

    avoid combo: combo may incr. risk of photosensitivity reaction (additive effects)

  • aripiprazole lauroxil
  • Hemiclor (chlorthalidone)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + aripiprazole lauroxil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • arsenic trioxide
  • Hemiclor (chlorthalidone)
    +
    arsenic trioxide
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + arsenic trioxide

    use alternative or monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • chlorothiazide
  • Hemiclor (chlorthalidone)
    +
    chlorothiazide
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + chlorothiazide

    avoid combo: combo may incr. risk of renal impairment, hyponatremia, seizures, hypokalemia, hypomagnesemia, hypercalcemia, other adverse effects (additive effects, duplicate therapy)

  • clofarabine
  • Hemiclor (chlorthalidone)
    +
    clofarabine
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + clofarabine

    avoid chlorthalidone during 5 day clofarabine tx; monitor CBC, renal fxn, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, severe hypotension, other adverse effects (additive effects)

  • hydrochlorothiazide
  • Hemiclor (chlorthalidone)
    +
    hydrochlorothiazide
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + hydrochlorothiazide

    avoid combo: combo may incr. risk of renal impairment, hyponatremia, hypokalemia, hypomagnesemia, cardiac arrhythmias, hypercalcemia, other adverse effects (additive effects, duplicate therapy)

  • indapamide
  • Hemiclor (chlorthalidone)
    +
    indapamide
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + indapamide

    avoid combo: combo may incr. risk of renal impairment, severe hyponatremia, hypokalemia, hypomagnesemia, hypercalcemia, other adverse effects (additive effects, duplicate therapy)

  • iodixanol
  • Hemiclor (chlorthalidone)
    +
    iodixanol
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + iodixanol

    avoid chlorthalidone prior to iodixanol administration: combo may incr. risk of nephrotoxicity (additive effects)

  • iomeprol
  • Hemiclor (chlorthalidone)
    +
    iomeprol
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + iomeprol

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • iopromide
  • Hemiclor (chlorthalidone)
    +
    iopromide
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + iopromide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • ioversol
  • Hemiclor (chlorthalidone)
    +
    ioversol
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + ioversol

    avoid chlorthalidone prior to ioversol administration: combo may incr. risk of nephrotoxicity (additive effects)

  • lofexidine
  • Hemiclor (chlorthalidone)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mannitol
  • Hemiclor (chlorthalidone)
    +
    mannitol
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + mannitol

    use alternative or monitor renal fxn, potassium, sodium, ECG: combo may incr. mannitol levels, risk of renal impairment, hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia (including life-threatening), seizures, neurotoxicity (including life-threatening), other adverse effects (additive effects)

  • metolazone
  • Hemiclor (chlorthalidone)
    +
    metolazone
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + metolazone

    avoid combo: combo may incr. risk of renal impairment, hyponatremia (including life-threatening), hypokalemia, hypomagnesemia, hypercalcemia, other adverse effects (additive effects, duplicate therapy)

  • porfimer
  • Hemiclor (chlorthalidone)
    +
    porfimer
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + porfimer

    avoid combo: combo may incr. risk of photosensitivity reaction (additive effects)

  • sulfamethoxazole
  • Hemiclor (chlorthalidone)
    +
    sulfamethoxazole
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + sulfamethoxazole

    avoid combo especially in elderly pts: combo may incr. risk of thrombocytopenia (mechanism unknown)

  • tretinoin topical
  • Hemiclor (chlorthalidone)
    +
    tretinoin topical
    1 interaction

    Avoid/Use Alternative

    chlorthalidone + tretinoin topical

    consider alternative, especially if tretinoin topical cosmetic use: combo may incr. risk of phototoxicity or augment phototoxic reaction (possible additive effects)

Monitor/Modify Tx

  • abaloparatide
  • Hemiclor (chlorthalidone)
    +
    abaloparatide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + abaloparatide

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • abiraterone acetate
  • Hemiclor (chlorthalidone)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + abiraterone acetate

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • acarbose
  • Hemiclor (chlorthalidone)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acetazolamide
  • Hemiclor (chlorthalidone)
    +
    acetazolamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + acetazolamide

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects)

  • acyclovir
  • Hemiclor (chlorthalidone)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + acyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Hemiclor (chlorthalidone)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + adefovir dipivoxil

    monitor renal fxn: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effects (renal excretion decreased, additive effects)

  • albuterol
  • Hemiclor (chlorthalidone)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + albuterol

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • albuterol inhaled
  • Hemiclor (chlorthalidone)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + albuterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • alfentanil
  • Hemiclor (chlorthalidone)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • alfuzosin
  • Hemiclor (chlorthalidone)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Hemiclor (chlorthalidone)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + aliskiren

    monitor renal fxn: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • allopurinol
  • Hemiclor (chlorthalidone)
    +
    allopurinol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + allopurinol

    monitor renal fxn, uric acid levels: combo may incr. risk of nephrotoxicity; may decr. allopurinol efficacy (additive effects; antagonistic effects)

  • almotriptan
  • Hemiclor (chlorthalidone)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + almotriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • aloe
  • Hemiclor (chlorthalidone)
    +
    aloe
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + aloe

    monitor potassium w/ aloe laxative doses: combo may incr. risk of hypokalemia (additive effects)

  • alogliptin
  • Hemiclor (chlorthalidone)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprostadil intracavernous
  • Hemiclor (chlorthalidone)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension (additive effects)

  • amantadine
  • Hemiclor (chlorthalidone)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Hemiclor (chlorthalidone)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amifostine

    D/C chlorthalidone 24h before amifostine admin; monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • amikacin inhaled
  • Hemiclor (chlorthalidone)
    +
    amikacin inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amikacin inhaled

    monitor renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amiloride
  • Hemiclor (chlorthalidone)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amiloride

    monitor renal function, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • amitriptyline
  • Hemiclor (chlorthalidone)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Hemiclor (chlorthalidone)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amphetamine
  • Hemiclor (chlorthalidone)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphotericin
  • Hemiclor (chlorthalidone)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + amphotericin

    monitor renal fxn, magnesium, potassium, ECG: combo may incr. risk of nephrotoxicity, hypomagnesemia, hypokalemia, cardiac arrhythmias (additive effects)

  • anthrax immune globulin
  • Hemiclor (chlorthalidone)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + anthrax immune globulin

    monitor renal fxn; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • apomorphine
  • Hemiclor (chlorthalidone)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Hemiclor (chlorthalidone)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension (additive effects)

  • arformoterol inhaled
  • Hemiclor (chlorthalidone)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + arformoterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • aripiprazole bimonthly injection
  • Hemiclor (chlorthalidone)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole monthly injection
  • Hemiclor (chlorthalidone)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Hemiclor (chlorthalidone)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • armodafinil
  • Hemiclor (chlorthalidone)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + armodafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • articaine
  • Hemiclor (chlorthalidone)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + articaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • asciminib
  • Hemiclor (chlorthalidone)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + asciminib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • asenapine
  • Hemiclor (chlorthalidone)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • asparaginase
  • Hemiclor (chlorthalidone)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + asparaginase

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • aspirin
  • Hemiclor (chlorthalidone)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + aspirin

    monitor BP, renal fxn: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • atogepant
  • Hemiclor (chlorthalidone)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + atogepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Hemiclor (chlorthalidone)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + atomoxetine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atropine ophthalmic
  • Hemiclor (chlorthalidone)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + atropine ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • auranofin
  • Hemiclor (chlorthalidone)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + auranofin

    monitor renal fxn: combo may incr. auranofin levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • avanafil
  • Hemiclor (chlorthalidone)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • axitinib
  • Hemiclor (chlorthalidone)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + axitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • azilsartan medoxomil
  • Hemiclor (chlorthalidone)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + azilsartan medoxomil

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • balsalazide
  • Hemiclor (chlorthalidone)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + balsalazide

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • benazepril
  • Hemiclor (chlorthalidone)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + benazepril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • benzphetamine
  • Hemiclor (chlorthalidone)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + benzphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • berberine
  • Hemiclor (chlorthalidone)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + berberine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • betamethasone
  • Hemiclor (chlorthalidone)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + betamethasone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • betaxolol ophthalmic
  • Hemiclor (chlorthalidone)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bethanechol
  • Hemiclor (chlorthalidone)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bethanechol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bevacizumab
  • Hemiclor (chlorthalidone)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bevacizumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bexagliflozin
  • Hemiclor (chlorthalidone)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bexagliflozin

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bismuth subsalicylate
  • Hemiclor (chlorthalidone)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bortezomib
  • Hemiclor (chlorthalidone)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • botulism immune globulin
  • Hemiclor (chlorthalidone)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + botulism immune globulin

    monitor renal fxn; use lowest botulism immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • brexpiprazole
  • Hemiclor (chlorthalidone)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • brigatinib
  • Hemiclor (chlorthalidone)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + brigatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brimonidine ophthalmic
  • Hemiclor (chlorthalidone)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • brimonidine topical
  • Hemiclor (chlorthalidone)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Hemiclor (chlorthalidone)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • budesonide
  • Hemiclor (chlorthalidone)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + budesonide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • bumetanide
  • Hemiclor (chlorthalidone)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bumetanide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia, other adverse effects (additive effects, duplicate therapy)

  • bupivacaine
  • Hemiclor (chlorthalidone)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bupivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bupivacaine liposomal
  • Hemiclor (chlorthalidone)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • buprenorphine
  • Hemiclor (chlorthalidone)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • bupropion
  • Hemiclor (chlorthalidone)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + bupropion

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • burosumab
  • Hemiclor (chlorthalidone)
    +
    burosumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + burosumab

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • butalbital
  • Hemiclor (chlorthalidone)
    +
    butalbital
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + butalbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • butorphanol
  • Hemiclor (chlorthalidone)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + butorphanol

    monitor BP: combo may incr. risk of hypotension, including syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • cabergoline
  • Hemiclor (chlorthalidone)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cabozantinib
  • Hemiclor (chlorthalidone)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cabozantinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine
  • Hemiclor (chlorthalidone)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + caffeine

    monitor BP; avoid excessive caffeine intake: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine citrate
  • Hemiclor (chlorthalidone)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + caffeine citrate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • calcipotriene topical
  • Hemiclor (chlorthalidone)
    +
    calcipotriene topical
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcipotriene topical

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcitriol
  • Hemiclor (chlorthalidone)
    +
    calcitriol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcitriol

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcitriol topical
  • Hemiclor (chlorthalidone)
    +
    calcitriol topical
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcitriol topical

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium acetate
  • Hemiclor (chlorthalidone)
    +
    calcium acetate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcium acetate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium carbonate
  • Hemiclor (chlorthalidone)
    +
    calcium carbonate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcium carbonate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium chloride
  • Hemiclor (chlorthalidone)
    +
    calcium chloride
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcium chloride

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium citrate
  • Hemiclor (chlorthalidone)
    +
    calcium citrate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcium citrate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • calcium gluconate
  • Hemiclor (chlorthalidone)
    +
    calcium gluconate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + calcium gluconate

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • canagliflozin
  • Hemiclor (chlorthalidone)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + canagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • candesartan cilexetil
  • Hemiclor (chlorthalidone)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + candesartan cilexetil

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • cannabis
  • Hemiclor (chlorthalidone)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cannabis

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • capecitabine
  • Hemiclor (chlorthalidone)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + capecitabine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • captopril
  • Hemiclor (chlorthalidone)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + captopril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • carbamazepine
  • Hemiclor (chlorthalidone)
    +
    carbamazepine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + carbamazepine

    monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects)

  • carboplatin
  • Hemiclor (chlorthalidone)
    +
    carboplatin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + carboplatin

    monitor CBC, renal fxn, magnesium: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, hypomagnesemia, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Hemiclor (chlorthalidone)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + carfilzomib

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cariprazine
  • Hemiclor (chlorthalidone)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carteolol ophthalmic
  • Hemiclor (chlorthalidone)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • celecoxib
  • Hemiclor (chlorthalidone)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + celecoxib

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • cetuximab
  • Hemiclor (chlorthalidone)
    +
    cetuximab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cetuximab

    monitor potassium, magnesium: combo may incr. risk of hypokalemia, hypomagnesemia (additive effects)

  • chloroprocaine
  • Hemiclor (chlorthalidone)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + chloroprocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • chlorpromazine
  • Hemiclor (chlorthalidone)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cholecalciferol (vitamin D3)
  • Hemiclor (chlorthalidone)
    +
    cholecalciferol (vitamin D3)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cholecalciferol (vitamin D3)

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • cholestyramine
  • Hemiclor (chlorthalidone)
    +
    cholestyramine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cholestyramine

    give chlorthalidone at least 1h before or 4-6h after each cholestyramine dose: combo may decr. chlorthalidone levels, efficacy (absorption decreased/delayed)

  • cidofovir
  • Hemiclor (chlorthalidone)
    +
    cidofovir
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cidofovir

    monitor CBC, renal fxn: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • cilostazol
  • Hemiclor (chlorthalidone)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cilostazol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cisplatin
  • Hemiclor (chlorthalidone)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cisplatin

    monitor CBC, renal fxn, electrolytes, ototoxicity: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, hypokalemia, hyponatremia, hypomagnesemia, tetany, auditory, vestibular, other adverse effects (additive effects)

  • citalopram
  • Hemiclor (chlorthalidone)
    +
    citalopram
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + citalopram

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • clindamycin
  • Hemiclor (chlorthalidone)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + clindamycin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • clomipramine
  • Hemiclor (chlorthalidone)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + clomipramine

    monitor BP, sodium: combo may incr. risk of hypotension (including orthostasis), hyponatremia (additive effects)

  • clonidine
  • Hemiclor (chlorthalidone)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Hemiclor (chlorthalidone)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + clozapine

    monitor BP, HR: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cocaine
  • Hemiclor (chlorthalidone)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cocaine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • codeine
  • Hemiclor (chlorthalidone)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + codeine

    monitor BP: combo may decr. chlorthalidone efficacy; may incr. risk of severe hypotension, including orthostasis, syncope (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • coenzyme Q-10
  • Hemiclor (chlorthalidone)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • colesevelam
  • Hemiclor (chlorthalidone)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • colestipol
  • Hemiclor (chlorthalidone)
    +
    colestipol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + colestipol

    give chlorthalidone at least 1h before or 4h after each colestipol dose: combo may decr. chlorthalidone levels, efficacy (absorption decreased/delayed)

  • colistimethate
  • Hemiclor (chlorthalidone)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + colistimethate

    monitor renal fxn: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • copanlisib
  • Hemiclor (chlorthalidone)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + copanlisib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects, copanlisib may cause infusion-related HTN)

  • copper histidinate
  • Hemiclor (chlorthalidone)
    +
    copper histidinate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + copper histidinate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • corticotropin
  • Hemiclor (chlorthalidone)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + corticotropin

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cortisone
  • Hemiclor (chlorthalidone)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cortisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • creatine
  • Hemiclor (chlorthalidone)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + creatine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • crizotinib
  • Hemiclor (chlorthalidone)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + crizotinib

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • cyclophosphamide
  • Hemiclor (chlorthalidone)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cyclophosphamide

    monitor CBC, renal, cardiac fxn, sodium: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, hyponatremia (including life-threatening), other adverse effects (additive effects)

  • cyclosporine
  • Hemiclor (chlorthalidone)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cyclosporine

    monitor renal fxn, magnesium, BP: combo may incr. risk of nephrotoxicity, hypomagnesemia, seizures; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cytomegalovirus immune globulin
  • Hemiclor (chlorthalidone)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + cytomegalovirus immune globulin

    monitor renal fxn; use lowest cytomegalovirus immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • danazol
  • Hemiclor (chlorthalidone)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + danazol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dapagliflozin
  • Hemiclor (chlorthalidone)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dapagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • darbepoetin alfa
  • Hemiclor (chlorthalidone)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + darbepoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • decitabine
  • Hemiclor (chlorthalidone)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + decitabine

    monitor potassium w/ IV decitabine use: combo may incr. risk of hypokalemia (additive effects)

  • deferasirox
  • Hemiclor (chlorthalidone)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + deferasirox

    monitor CBC, renal fxn, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Hemiclor (chlorthalidone)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + deferoxamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • deflazacort
  • Hemiclor (chlorthalidone)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + deflazacort

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • denileukin diftitox
  • Hemiclor (chlorthalidone)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Hemiclor (chlorthalidone)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + desflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • desipramine
  • Hemiclor (chlorthalidone)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + desipramine

    monitor BP, sodium: combo may incr. risk of hypotension (including orthostasis), hyponatremia (additive effects)

  • desmopressin
  • Hemiclor (chlorthalidone)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + desmopressin

    monitor sodium, BP: combo may incr. risk of hyponatremia, including life-threatening; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • desvenlafaxine
  • Hemiclor (chlorthalidone)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + desvenlafaxine

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • dexamethasone
  • Hemiclor (chlorthalidone)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dexamethasone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • dexlansoprazole
  • Hemiclor (chlorthalidone)
    +
    dexlansoprazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dexlansoprazole

    monitor magnesium, especially w/ dexlansoprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • dexmedetomidine
  • Hemiclor (chlorthalidone)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Hemiclor (chlorthalidone)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • dexmethylphenidate
  • Hemiclor (chlorthalidone)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dexmethylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dextroamphetamine
  • Hemiclor (chlorthalidone)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dextroamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diazoxide
  • Hemiclor (chlorthalidone)
    +
    diazoxide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + diazoxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • dichlorphenamide
  • Hemiclor (chlorthalidone)
    +
    dichlorphenamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dichlorphenamide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • diclofenac
  • Hemiclor (chlorthalidone)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + diclofenac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • diclofenac topical
  • Hemiclor (chlorthalidone)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + diclofenac topical

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • diethylpropion
  • Hemiclor (chlorthalidone)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + diethylpropion

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diflunisal
  • Hemiclor (chlorthalidone)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + diflunisal

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • digoxin
  • Hemiclor (chlorthalidone)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + digoxin

    monitor electrolytes: combo may incr. risk of digoxin toxicity, cardiac arrhythmias (electrolyte abnormalities may incr. digoxin sensitivity)

  • dihydrocodeine
  • Hemiclor (chlorthalidone)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • dihydroergotamine
  • Hemiclor (chlorthalidone)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dihydroergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dinutuximab
  • Hemiclor (chlorthalidone)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dinutuximab

    monitor BP, potassium, sodium: combo may incr. risk of severe hypotension, severe hyponatremia, hypokalemia (additive effects)

  • dipyridamole
  • Hemiclor (chlorthalidone)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • dofetilide
  • Hemiclor (chlorthalidone)
    +
    dofetilide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dofetilide

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (electrolyte abnormalities)

  • doxapram
  • Hemiclor (chlorthalidone)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + doxapram

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxazosin
  • Hemiclor (chlorthalidone)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Hemiclor (chlorthalidone)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • doxercalciferol
  • Hemiclor (chlorthalidone)
    +
    doxercalciferol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + doxercalciferol

    monitor calcium: combo may incr. risk of hypercalcemia, cardiac arrhythmias, seizures (additive effects)

  • dronabinol
  • Hemiclor (chlorthalidone)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dronabinol

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • droxidopa
  • Hemiclor (chlorthalidone)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + droxidopa

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • dulaglutide
  • Hemiclor (chlorthalidone)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Hemiclor (chlorthalidone)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + duloxetine

    monitor BP, sodium: combo may incr. risk of hyponatremia, hypotension, including orthostasis (additive effects)

  • eletriptan
  • Hemiclor (chlorthalidone)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + eletriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • emapalumab
  • Hemiclor (chlorthalidone)
    +
    emapalumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + emapalumab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • empagliflozin
  • Hemiclor (chlorthalidone)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + empagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • enalapril
  • Hemiclor (chlorthalidone)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + enalapril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • enalaprilat
  • Hemiclor (chlorthalidone)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + enalaprilat

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • entacapone
  • Hemiclor (chlorthalidone)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Hemiclor (chlorthalidone)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + entrectinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • ephedra
  • Hemiclor (chlorthalidone)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ephedra

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Hemiclor (chlorthalidone)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ephedrine injection

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine oral
  • Hemiclor (chlorthalidone)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ephedrine oral

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epinephrine
  • Hemiclor (chlorthalidone)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + epinephrine

    monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • epinephrine inhaled
  • Hemiclor (chlorthalidone)
    +
    epinephrine inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + epinephrine inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Hemiclor (chlorthalidone)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + epoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoprostenol
  • Hemiclor (chlorthalidone)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • eptinezumab
  • Hemiclor (chlorthalidone)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + eptinezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • erenumab
  • Hemiclor (chlorthalidone)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + erenumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ergocalciferol (vitamin D2)
  • Hemiclor (chlorthalidone)
    +
    ergocalciferol (vitamin D2)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ergocalciferol (vitamin D2)

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • ergotamine
  • Hemiclor (chlorthalidone)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ertugliflozin
  • Hemiclor (chlorthalidone)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ertugliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • escitalopram
  • Hemiclor (chlorthalidone)
    +
    escitalopram
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + escitalopram

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • esketamine
  • Hemiclor (chlorthalidone)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + esketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • eslicarbazepine acetate
  • Hemiclor (chlorthalidone)
    +
    eslicarbazepine acetate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + eslicarbazepine acetate

    monitor sodium: combo may incr. risk of hyponatremia (including life-threatening), seizures (additive effects)

  • esomeprazole
  • Hemiclor (chlorthalidone)
    +
    esomeprazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + esomeprazole

    monitor magnesium, especially w/ esomeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • estetrol (contraceptive)
  • Hemiclor (chlorthalidone)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + estetrol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estradiol (contraceptive)
  • Hemiclor (chlorthalidone)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethacrynic acid
  • Hemiclor (chlorthalidone)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ethacrynic acid

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia (additive effects)

  • ethanol (alcoholic beverage)
  • Hemiclor (chlorthalidone)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ethanol (alcoholic beverage)

    monitor BP: combo may alter BP control, initially incr. risk of severe hypotension (including orthostasis), followed by HTN (additive effects, antagonistic effects, acute alcohol intake may have biphasic effects on blood pressure; chronic alcohol use may further increase HTN risk)

  • ethanol injection
  • Hemiclor (chlorthalidone)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ethinyl estradiol (contraceptive)
  • Hemiclor (chlorthalidone)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ethinyl estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etodolac
  • Hemiclor (chlorthalidone)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + etodolac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • etrasimod
  • Hemiclor (chlorthalidone)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + etrasimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etripamil nasal
  • Hemiclor (chlorthalidone)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • exenatide
  • Hemiclor (chlorthalidone)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • febuxostat
  • Hemiclor (chlorthalidone)
    +
    febuxostat
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + febuxostat

    monitor uric acid levels: combo may decr. febuxostat efficacy (antagonistic effects)

  • fenfluramine
  • Hemiclor (chlorthalidone)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fenfluramine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Hemiclor (chlorthalidone)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fenoprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • fentanyl
  • Hemiclor (chlorthalidone)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • ferumoxytol
  • Hemiclor (chlorthalidone)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ferumoxytol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • fingolimod
  • Hemiclor (chlorthalidone)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fingolimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • flaxseed
  • Hemiclor (chlorthalidone)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + flaxseed

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • flibanserin
  • Hemiclor (chlorthalidone)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • flucytosine
  • Hemiclor (chlorthalidone)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + flucytosine

    monitor CBC, renal fxn, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fludrocortisone
  • Hemiclor (chlorthalidone)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fludrocortisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • fluoxetine
  • Hemiclor (chlorthalidone)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fluoxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • fluphenazine
  • Hemiclor (chlorthalidone)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flurbiprofen
  • Hemiclor (chlorthalidone)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + flurbiprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • fluvoxamine
  • Hemiclor (chlorthalidone)
    +
    fluvoxamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fluvoxamine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • formoterol inhaled
  • Hemiclor (chlorthalidone)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + formoterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • foscarnet
  • Hemiclor (chlorthalidone)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + foscarnet

    monitor CBC, renal fxn, magnesium, potassium, ECG: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, hypomagnesemia, hypokalemia, QT prolongation, cardiac arrhythmias, tetany, seizures, other adverse effects (additive effects)

  • fosfomycin injection
  • Hemiclor (chlorthalidone)
    +
    fosfomycin injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fosfomycin injection

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • fosinopril
  • Hemiclor (chlorthalidone)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fosinopril

    monitor renal fxn, BP, sodium: combo may incr. risk of renal impairment, hypotension, hyponatremia (additive effects)

  • foslevodopa
  • Hemiclor (chlorthalidone)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fostamatinib
  • Hemiclor (chlorthalidone)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fostamatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fremanezumab
  • Hemiclor (chlorthalidone)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fremanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • frovatriptan
  • Hemiclor (chlorthalidone)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + frovatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fruquintinib
  • Hemiclor (chlorthalidone)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + fruquintinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • furosemide
  • Hemiclor (chlorthalidone)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + furosemide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia (additive effects)

  • galcanezumab
  • Hemiclor (chlorthalidone)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + galcanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ganciclovir
  • Hemiclor (chlorthalidone)
    +
    ganciclovir
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • garlic
  • Hemiclor (chlorthalidone)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension (additive effects)

  • gentamicin
  • Hemiclor (chlorthalidone)
    +
    gentamicin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + gentamicin

    monitor gentamicin levels, renal fxn, magnesium, ototoxicity: combo may incr. gentamicin levels, risk of nephrotoxicity, hypomagnesemia, tetany, auditory, vestibular, other adverse effects (additive effects)

  • gilteritinib
  • Hemiclor (chlorthalidone)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + gilteritinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • glimepiride
  • Hemiclor (chlorthalidone)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Hemiclor (chlorthalidone)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Hemiclor (chlorthalidone)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Hemiclor (chlorthalidone)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • haloperidol
  • Hemiclor (chlorthalidone)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hoodia
  • Hemiclor (chlorthalidone)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + hoodia

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydralazine
  • Hemiclor (chlorthalidone)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + hydralazine

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • hydrocodone
  • Hemiclor (chlorthalidone)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • hydrocortisone
  • Hemiclor (chlorthalidone)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + hydrocortisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • hydromorphone
  • Hemiclor (chlorthalidone)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • hydroxocobalamin IV
  • Hemiclor (chlorthalidone)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + hydroxocobalamin IV

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibrutinib
  • Hemiclor (chlorthalidone)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ibrutinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibuprofen
  • Hemiclor (chlorthalidone)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ibuprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • ibuprofen lysine
  • Hemiclor (chlorthalidone)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ibuprofen lysine

    monitor renal fxn: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • ifosfamide
  • Hemiclor (chlorthalidone)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ifosfamide

    monitor CBC, sodium, renal, cardiac fxn: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, hyponatremia, other adverse effects (additive effects)

  • iloperidone
  • Hemiclor (chlorthalidone)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Hemiclor (chlorthalidone)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + iloprost

    monitor BP; consider holding chlorthalidone during iloprost admin.: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Hemiclor (chlorthalidone)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • immune globulin
  • Hemiclor (chlorthalidone)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + immune globulin

    monitor renal fxn; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • indomethacin
  • Hemiclor (chlorthalidone)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + indomethacin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • insulin
  • Hemiclor (chlorthalidone)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + insulin

    monitor glucose, potassium: combo may incr. risk of hypokalemia; may decr. antidiabetic agent efficacy (additive effects, antagonistic effects)

  • iohexol
  • Hemiclor (chlorthalidone)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + iohexol

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iopamidol
  • Hemiclor (chlorthalidone)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + iopamidol

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iothalamate meglumine
  • Hemiclor (chlorthalidone)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + iothalamate meglumine

    if IV iothalamate meglumine use, monitor renal function; retrograde cystography and cystourethrography use OK: combo may incr. risk of nephrotoxicity (additive effects)

  • irbesartan
  • Hemiclor (chlorthalidone)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + irbesartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • iron sucrose
  • Hemiclor (chlorthalidone)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + iron sucrose

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoflurane
  • Hemiclor (chlorthalidone)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + isoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoproterenol
  • Hemiclor (chlorthalidone)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + isoproterenol

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • isosorbide dinitrate
  • Hemiclor (chlorthalidone)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isosorbide mononitrate
  • Hemiclor (chlorthalidone)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • ketamine
  • Hemiclor (chlorthalidone)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketoprofen
  • Hemiclor (chlorthalidone)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ketoprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • ketorolac
  • Hemiclor (chlorthalidone)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ketorolac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • landiolol
  • Hemiclor (chlorthalidone)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + landiolol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • lanreotide
  • Hemiclor (chlorthalidone)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lanreotide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lansoprazole
  • Hemiclor (chlorthalidone)
    +
    lansoprazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lansoprazole

    monitor magnesium, especially w/ lansoprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • leflunomide
  • Hemiclor (chlorthalidone)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + leflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lenalidomide
  • Hemiclor (chlorthalidone)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lenalidomide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • lenvatinib
  • Hemiclor (chlorthalidone)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lenvatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • leucovorin
  • Hemiclor (chlorthalidone)
    +
    leucovorin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + leucovorin

    monitor calcium: combo may increase risk of hypercalcemia (additive effects, (levo)leucovorin injection contains calcium)

  • levalbuterol inhaled
  • Hemiclor (chlorthalidone)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + levalbuterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • levobunolol ophthalmic
  • Hemiclor (chlorthalidone)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • levodopa
  • Hemiclor (chlorthalidone)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levomilnacipran
  • Hemiclor (chlorthalidone)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + levomilnacipran

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • levorphanol
  • Hemiclor (chlorthalidone)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • levothyroxine
  • Hemiclor (chlorthalidone)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + levothyroxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • licorice
  • Hemiclor (chlorthalidone)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + licorice

    monitor BP, potassium w/ large amounts of licorice: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • lidocaine
  • Hemiclor (chlorthalidone)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lidocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • linagliptin
  • Hemiclor (chlorthalidone)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • linezolid
  • Hemiclor (chlorthalidone)
    +
    linezolid
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + linezolid

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • liothyronine
  • Hemiclor (chlorthalidone)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + liothyronine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • liraglutide
  • Hemiclor (chlorthalidone)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisdexamfetamine
  • Hemiclor (chlorthalidone)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lisdexamfetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lisinopril
  • Hemiclor (chlorthalidone)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lisinopril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • lithium
  • Hemiclor (chlorthalidone)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lithium

    monitor lithium levels, renal fxn; consider decr. lithium start dose: combo may incr. lithium levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • lixisenatide
  • Hemiclor (chlorthalidone)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lomustine
  • Hemiclor (chlorthalidone)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lomustine

    monitor CBC, renal fxn: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • lorlatinib
  • Hemiclor (chlorthalidone)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lorlatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • losartan
  • Hemiclor (chlorthalidone)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + losartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • loxapine
  • Hemiclor (chlorthalidone)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Hemiclor (chlorthalidone)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • lumacaftor/ivacaftor
  • Hemiclor (chlorthalidone)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lumacaftor/ ivacaftor

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumateperone
  • Hemiclor (chlorthalidone)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Hemiclor (chlorthalidone)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • luspatercept
  • Hemiclor (chlorthalidone)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + luspatercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lutetium Lu 177 dotatate
  • Hemiclor (chlorthalidone)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lutetium Lu 177 dotatate

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Hemiclor (chlorthalidone)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + lutetium Lu 177 vipivotide tetraxetan

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium citrate
  • Hemiclor (chlorthalidone)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + magnesium citrate

    monitor renal fxn, sodium, potassium, consider monitoring ECG if magnesium citrate bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, renal impairment, hyponatremia, seizures (additive effects)

  • magnesium salicylate
  • Hemiclor (chlorthalidone)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + magnesium salicylate

    monitor renal fxn, BP w/ high-dose magnesium salicylate: combo may incr. risk of renal impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • magnesium sulfate
  • Hemiclor (chlorthalidone)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • maraviroc
  • Hemiclor (chlorthalidone)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meclofenamate
  • Hemiclor (chlorthalidone)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + meclofenamate

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • mefenamic acid
  • Hemiclor (chlorthalidone)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mefenamic acid

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • meloxicam
  • Hemiclor (chlorthalidone)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + meloxicam

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • meperidine
  • Hemiclor (chlorthalidone)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • mepivacaine
  • Hemiclor (chlorthalidone)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mepivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • mesalamine
  • Hemiclor (chlorthalidone)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mesalamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • mesalamine rectal
  • Hemiclor (chlorthalidone)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mesalamine rectal

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • metformin
  • Hemiclor (chlorthalidone)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methadone
  • Hemiclor (chlorthalidone)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • methamphetamine
  • Hemiclor (chlorthalidone)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methazolamide
  • Hemiclor (chlorthalidone)
    +
    methazolamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methazolamide

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects)

  • methohexital
  • Hemiclor (chlorthalidone)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methohexital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methotrexate
  • Hemiclor (chlorthalidone)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methotrexate

    monitor CBC, renal fxn: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Hemiclor (chlorthalidone)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylene blue injection
  • Hemiclor (chlorthalidone)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylergonovine
  • Hemiclor (chlorthalidone)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methylergonovine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylphenidate
  • Hemiclor (chlorthalidone)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylprednisolone
  • Hemiclor (chlorthalidone)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methylprednisolone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • methyltestosterone
  • Hemiclor (chlorthalidone)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + methyltestosterone

    monitor BP, calcium, especially if breast CA use: combo may incr. risk of hypercalcemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • metoclopramide
  • Hemiclor (chlorthalidone)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + metoclopramide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • midazolam
  • Hemiclor (chlorthalidone)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + midazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • midodrine
  • Hemiclor (chlorthalidone)
    +
    midodrine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + midodrine

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • mifepristone
  • Hemiclor (chlorthalidone)
    +
    mifepristone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mifepristone

    monitor potassium if daily mifepristone use: combo may incr. risk of hypokalemia (additive effects)

  • miglitol
  • Hemiclor (chlorthalidone)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milnacipran
  • Hemiclor (chlorthalidone)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + milnacipran

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • milrinone
  • Hemiclor (chlorthalidone)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + milrinone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • milsaperidone
  • Hemiclor (chlorthalidone)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mirabegron
  • Hemiclor (chlorthalidone)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mirabegron

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirtazapine
  • Hemiclor (chlorthalidone)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mirtazapine

    monitor sodium, BP: combo may incr. risk of hyponatremia, hypotension, including orthostasis (additive effects)

  • mitomycin
  • Hemiclor (chlorthalidone)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + mitomycin

    monitor renal fxn; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of nephrotoxicity (additive effects)

  • modafinil
  • Hemiclor (chlorthalidone)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + modafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • moexipril
  • Hemiclor (chlorthalidone)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + moexipril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • molindone
  • Hemiclor (chlorthalidone)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • morphine
  • Hemiclor (chlorthalidone)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • motixafortide
  • Hemiclor (chlorthalidone)
    +
    motixafortide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + motixafortide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • nabumetone
  • Hemiclor (chlorthalidone)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nabumetone

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • nalbuphine
  • Hemiclor (chlorthalidone)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • naphazoline ophthalmic
  • Hemiclor (chlorthalidone)
    +
    naphazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + naphazoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Hemiclor (chlorthalidone)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + naproxen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • naratriptan
  • Hemiclor (chlorthalidone)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + naratriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nateglinide
  • Hemiclor (chlorthalidone)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nattokinase
  • Hemiclor (chlorthalidone)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nattokinase

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • naxitamab
  • Hemiclor (chlorthalidone)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + naxitamab

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • necitumumab
  • Hemiclor (chlorthalidone)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + necitumumab

    monitor potassium, magnesium: combo may incr. risk of hypokalemia, hypomagnesemia (additive effects)

  • neomycin
  • Hemiclor (chlorthalidone)
    +
    neomycin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + neomycin

    if compromised gut wall allows for neomycin absorption, monitor renal fxn, ototoxicity: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • niacin (vitamin B3)
  • Hemiclor (chlorthalidone)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nicotine
  • Hemiclor (chlorthalidone)
    +
    nicotine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nicotine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nilotinib
  • Hemiclor (chlorthalidone)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nilotinib

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects)

  • niraparib
  • Hemiclor (chlorthalidone)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + niraparib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nitric oxide
  • Hemiclor (chlorthalidone)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nitric oxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nitrite
  • Hemiclor (chlorthalidone)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including syncope (additive effects)

  • nitroglycerin
  • Hemiclor (chlorthalidone)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Hemiclor (chlorthalidone)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • nortriptyline
  • Hemiclor (chlorthalidone)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nusinersen
  • Hemiclor (chlorthalidone)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + nusinersen

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • obinutuzumab
  • Hemiclor (chlorthalidone)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + obinutuzumab

    monitor BP: combo may incr. risk of hypotension; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • olanzapine
  • Hemiclor (chlorthalidone)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + olanzapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Hemiclor (chlorthalidone)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • olmesartan medoxomil
  • Hemiclor (chlorthalidone)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + olmesartan medoxomil

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • olodaterol inhaled
  • Hemiclor (chlorthalidone)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + olodaterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • olsalazine
  • Hemiclor (chlorthalidone)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + olsalazine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • omeprazole
  • Hemiclor (chlorthalidone)
    +
    omeprazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + omeprazole

    monitor magnesium, especially w/ omeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • opicapone
  • Hemiclor (chlorthalidone)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Hemiclor (chlorthalidone)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • osilodrostat
  • Hemiclor (chlorthalidone)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + osilodrostat

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • oxaliplatin
  • Hemiclor (chlorthalidone)
    +
    oxaliplatin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxaliplatin

    monitor ECG, CBC, renal fxn, ototoxicity: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • oxaprozin
  • Hemiclor (chlorthalidone)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxaprozin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • oxazepam
  • Hemiclor (chlorthalidone)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxazepam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • oxcarbazepine
  • Hemiclor (chlorthalidone)
    +
    oxcarbazepine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxcarbazepine

    monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects)

  • oxycodone
  • Hemiclor (chlorthalidone)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • oxymetazoline nasal
  • Hemiclor (chlorthalidone)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxymetazoline nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline ophthalmic
  • Hemiclor (chlorthalidone)
    +
    oxymetazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxymetazoline ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline topical
  • Hemiclor (chlorthalidone)
    +
    oxymetazoline topical
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxymetazoline topical

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymorphone
  • Hemiclor (chlorthalidone)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • oxytocin
  • Hemiclor (chlorthalidone)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + oxytocin

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects)

  • ozanimod
  • Hemiclor (chlorthalidone)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ozanimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • paliperidone
  • Hemiclor (chlorthalidone)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Hemiclor (chlorthalidone)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + palopegteriparatide

    monitor BP, calcium: combo may incr. risk of hypercalcemia, hypotension, including orthostasis, syncope (additive effects)

  • pamidronate
  • Hemiclor (chlorthalidone)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pamidronate

    monitor renal fxn, potassium, magnesium: combo may incr. pamidronate levels, risk of nephrotoxicity, hypokalemia, hypomagnesemia, other adverse effects (additive effects)

  • panitumumab
  • Hemiclor (chlorthalidone)
    +
    panitumumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + panitumumab

    monitor potassium, magnesium: combo may incr. risk of hypokalemia, hypomagnesemia (additive effects)

  • pantoprazole
  • Hemiclor (chlorthalidone)
    +
    pantoprazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pantoprazole

    monitor magnesium, especially w/ pantoprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • paricalcitol
  • Hemiclor (chlorthalidone)
    +
    paricalcitol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + paricalcitol

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • paromomycin
  • Hemiclor (chlorthalidone)
    +
    paromomycin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + paromomycin

    if compromised gut wall allows for paromomycin absorption, monitor renal fxn, ototoxicity: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • paroxetine
  • Hemiclor (chlorthalidone)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + paroxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • patiromer
  • Hemiclor (chlorthalidone)
    +
    patiromer
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + patiromer

    monitor magnesium: combo may incr. risk of hypomagnesemia (additive effects)

  • pazopanib
  • Hemiclor (chlorthalidone)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pazopanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pegloticase
  • Hemiclor (chlorthalidone)
    +
    pegloticase
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pegloticase

    monitor uric acid levels: combo may decr. pegloticase efficacy (antagonistic effects)

  • pemetrexed
  • Hemiclor (chlorthalidone)
    +
    pemetrexed
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pemetrexed

    monitor CBC, renal fxn: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillamine
  • Hemiclor (chlorthalidone)
    +
    penicillamine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + penicillamine

    monitor CBC, renal fxn: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentamidine
  • Hemiclor (chlorthalidone)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pentamidine

    monitor renal fxn, BP: combo may incr. risk of nephrotoxicity, severe or life-threatening hypotension (additive effects)

  • pentazocine
  • Hemiclor (chlorthalidone)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • pentobarbital
  • Hemiclor (chlorthalidone)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pentobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pentostatin
  • Hemiclor (chlorthalidone)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pentostatin

    monitor CBC, renal fxn: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentoxifylline
  • Hemiclor (chlorthalidone)
    +
    pentoxifylline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pentoxifylline

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • perindopril
  • Hemiclor (chlorthalidone)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + perindopril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • perphenazine
  • Hemiclor (chlorthalidone)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pexidartinib
  • Hemiclor (chlorthalidone)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pexidartinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phendimetrazine
  • Hemiclor (chlorthalidone)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phendimetrazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenelzine
  • Hemiclor (chlorthalidone)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Hemiclor (chlorthalidone)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentermine
  • Hemiclor (chlorthalidone)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phentermine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Hemiclor (chlorthalidone)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phenylephrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine injection
  • Hemiclor (chlorthalidone)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phenylephrine injection

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • phenylephrine nasal
  • Hemiclor (chlorthalidone)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phenylephrine nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine ophthalmic
  • Hemiclor (chlorthalidone)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine rectal
  • Hemiclor (chlorthalidone)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + phenylephrine rectal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pioglitazone
  • Hemiclor (chlorthalidone)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • piroxicam
  • Hemiclor (chlorthalidone)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + piroxicam

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • plazomicin
  • Hemiclor (chlorthalidone)
    +
    plazomicin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + plazomicin

    monitor plazomicin levels, renal fxn, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • polyethylene glycol
  • Hemiclor (chlorthalidone)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + polyethylene glycol

    monitor renal fxn, sodium, potassium, consider monitoring ECG if polyethylene glycol bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia, seizures, renal impairment (additive effects)

  • polyethylene glycol/electrolytes
  • Hemiclor (chlorthalidone)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + polyethylene glycol/ electrolytes

    monitor renal fxn, sodium, potassium, consider monitoring ECG: combo may incr. risk of renal impairment, hyponatremia, seizures, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • polymyxin B
  • Hemiclor (chlorthalidone)
    +
    polymyxin B
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + polymyxin B

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ponatinib
  • Hemiclor (chlorthalidone)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ponatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ponesimod
  • Hemiclor (chlorthalidone)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ponesimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • posaconazole
  • Hemiclor (chlorthalidone)
    +
    posaconazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + posaconazole

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • pralsetinib
  • Hemiclor (chlorthalidone)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pralsetinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pramipexole
  • Hemiclor (chlorthalidone)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Hemiclor (chlorthalidone)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Hemiclor (chlorthalidone)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prednisolone
  • Hemiclor (chlorthalidone)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + prednisolone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • prednisone
  • Hemiclor (chlorthalidone)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + prednisone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • primidone
  • Hemiclor (chlorthalidone)
    +
    primidone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + primidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • probenecid
  • Hemiclor (chlorthalidone)
    +
    probenecid
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + probenecid

    monitor uric acid levels: combo may decr. probenecid efficacy (antagonistic effects)

  • procarbazine
  • Hemiclor (chlorthalidone)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + procarbazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • prochlorperazine
  • Hemiclor (chlorthalidone)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Hemiclor (chlorthalidone)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + promethazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propafenone
  • Hemiclor (chlorthalidone)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + propafenone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propofol
  • Hemiclor (chlorthalidone)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + propofol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • protriptyline
  • Hemiclor (chlorthalidone)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pseudoephedrine
  • Hemiclor (chlorthalidone)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + pseudoephedrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quetiapine
  • Hemiclor (chlorthalidone)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + quetiapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antihypertensive agent efficacy (peds patients) (additive effects, antagonistic effects)

  • quinapril
  • Hemiclor (chlorthalidone)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + quinapril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • quinidine (antiarrhythmic)
  • Hemiclor (chlorthalidone)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + quinidine (antiarrhythmic)

    monitor quinidine levels, ECG: combo may incr. quinidine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (renal excretion possibly decreased at higher urine pH)

  • quinidine (CYP2D6 inhibitor)
  • Hemiclor (chlorthalidone)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + quinidine (CYP2D6 inhibitor)

    monitor ECG: combo may incr. quinidine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (renal excretion possibly decreased at higher urine pH)

  • rabeprazole
  • Hemiclor (chlorthalidone)
    +
    rabeprazole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rabeprazole

    monitor magnesium, especially w/ rabeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • ramipril
  • Hemiclor (chlorthalidone)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ramipril

    monitor renal function, sodium, BP: combo may increase risk of renal impairment, hyponatremia, hypotension (additive effects)

  • ramucirumab
  • Hemiclor (chlorthalidone)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ramucirumab

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • rasagiline
  • Hemiclor (chlorthalidone)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rasburicase
  • Hemiclor (chlorthalidone)
    +
    rasburicase
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rasburicase

    monitor uric acid levels: combo may decr. rasburicase efficacy (antagonistic effects)

  • regorafenib
  • Hemiclor (chlorthalidone)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + regorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • remifentanil
  • Hemiclor (chlorthalidone)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • remimazolam
  • Hemiclor (chlorthalidone)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + remimazolam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • repaglinide
  • Hemiclor (chlorthalidone)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • Rho(D) immune globulin
  • Hemiclor (chlorthalidone)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + Rho(D) immune globulin

    monitor renal fxn; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • rimegepant
  • Hemiclor (chlorthalidone)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rimegepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • riociguat
  • Hemiclor (chlorthalidone)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + riociguat

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • ripretinib
  • Hemiclor (chlorthalidone)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ripretinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • risperidone
  • Hemiclor (chlorthalidone)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • rituximab
  • Hemiclor (chlorthalidone)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rituximab

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • rizatriptan
  • Hemiclor (chlorthalidone)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rizatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • romidepsin
  • Hemiclor (chlorthalidone)
    +
    romidepsin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + romidepsin

    monitor magnesium, sodium: combo may incr. risk of hypomagnesemia, hyponatremia (additive effects)

  • ropeginterferon alfa-2b
  • Hemiclor (chlorthalidone)
    +
    ropeginterferon alfa-2b
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ropeginterferon alfa-2b

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ropinirole
  • Hemiclor (chlorthalidone)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ropinirole

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • ropivacaine
  • Hemiclor (chlorthalidone)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ropivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • rosiglitazone
  • Hemiclor (chlorthalidone)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Hemiclor (chlorthalidone)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + rotigotine transdermal

    monitor BP: combo may alter blood pressure control (antagonistic effects, additive effects)

  • sacituzumab govitecan
  • Hemiclor (chlorthalidone)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sacituzumab govitecan

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sacubitril
  • Hemiclor (chlorthalidone)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Hemiclor (chlorthalidone)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • salmeterol inhaled
  • Hemiclor (chlorthalidone)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + salmeterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • salsalate
  • Hemiclor (chlorthalidone)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + salsalate

    monitor renal fxn, BP w/ high-dose salsalate: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • saxagliptin
  • Hemiclor (chlorthalidone)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Hemiclor (chlorthalidone)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Hemiclor (chlorthalidone)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selinexor
  • Hemiclor (chlorthalidone)
    +
    selinexor
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + selinexor

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia, including life-threatening (additive effects)

  • selpercatinib
  • Hemiclor (chlorthalidone)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + selpercatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • semaglutide
  • Hemiclor (chlorthalidone)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sertraline
  • Hemiclor (chlorthalidone)
    +
    sertraline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sertraline

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • sevoflurane
  • Hemiclor (chlorthalidone)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sevoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sildenafil
  • Hemiclor (chlorthalidone)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sildenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • silodosin
  • Hemiclor (chlorthalidone)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • siponimod
  • Hemiclor (chlorthalidone)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + siponimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sirolimus
  • Hemiclor (chlorthalidone)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sirolimus albumin-bound
  • Hemiclor (chlorthalidone)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sirolimus albumin-bound

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sitagliptin
  • Hemiclor (chlorthalidone)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sitagliptin

    monitor glucose, renal fxn: combo may incr. risk of nephrotoxicity; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • sodium benzoate
  • Hemiclor (chlorthalidone)
    +
    sodium benzoate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sodium benzoate

    monitor potassium, especially if hyperammonemia use: combo may incr. risk of hypokalemia (additive effects)

  • sodium ferric gluconate complex
  • Hemiclor (chlorthalidone)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sodium phenylacetate
  • Hemiclor (chlorthalidone)
    +
    sodium phenylacetate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sodium phenylacetate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sodium phenylbutyrate
  • Hemiclor (chlorthalidone)
    +
    sodium phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sodium phenylbutyrate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sodium picosulfate
  • Hemiclor (chlorthalidone)
    +
    sodium picosulfate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sodium picosulfate

    monitor renal function: combo may incr. risk of renal impairment (additive effects)

  • sodium polystyrene sulfonate
  • Hemiclor (chlorthalidone)
    +
    sodium polystyrene sulfonate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sodium polystyrene sulfonate

    monitor magnesium, potassium, ECG: combo may incr. risk of hypomagnesemia, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sodium thiosulfate
  • Hemiclor (chlorthalidone)
    +
    sodium thiosulfate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sodium thiosulfate

    if ototoxicity risk reduction use, monitor potassium; otherwise, caution advised: combo may incr. risk of hypokalemia (additive effects)

  • sorafenib
  • Hemiclor (chlorthalidone)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sotagliflozin
  • Hemiclor (chlorthalidone)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotalol
  • Hemiclor (chlorthalidone)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sotalol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sparsentan
  • Hemiclor (chlorthalidone)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sparsentan

    monitor BP, renal fxn: combo may incr. risk of nephrotoxicity, hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Hemiclor (chlorthalidone)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + spironolactone

    monitor renal fxn, magnesium, sodium: combo may incr. risk of renal impairment, hypomagnesemia, hyponatremia (additive effects)

  • streptomycin
  • Hemiclor (chlorthalidone)
    +
    streptomycin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + streptomycin

    monitor renal fxn, ototoxicity: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • streptozocin
  • Hemiclor (chlorthalidone)
    +
    streptozocin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + streptozocin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sufentanil
  • Hemiclor (chlorthalidone)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • sulfate bowel prep
  • Hemiclor (chlorthalidone)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sulfate bowel prep

    monitor renal fxn, sodium, potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, renal impairment, hyponatremia, seizures (additive effects)

  • sulindac
  • Hemiclor (chlorthalidone)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sulindac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • sumatriptan
  • Hemiclor (chlorthalidone)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sumatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sunitinib
  • Hemiclor (chlorthalidone)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + sunitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tacrolimus
  • Hemiclor (chlorthalidone)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tacrolimus

    monitor tacrolimus levels, renal fxn, magnesium, BP: combo may incr. tacrolimus levels, risk of nephrotoxicity, hypomagnesemia, other adverse effects; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • tadalafil
  • Hemiclor (chlorthalidone)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tadalafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tafasitamab
  • Hemiclor (chlorthalidone)
    +
    tafasitamab
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tafasitamab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • tagraxofusp
  • Hemiclor (chlorthalidone)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tagraxofusp

    monitor BP, sodium: combo may alter blood pressure control (antagonistic effects, additive effects)

  • tamsulosin
  • Hemiclor (chlorthalidone)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Hemiclor (chlorthalidone)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tapentadol

    monitor BP; consider chlorthalidone dose adjustment: combo may increase risk of severe hypotension, including orthostasis, syncope; may decrease chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • taurine
  • Hemiclor (chlorthalidone)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + taurine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • telavancin
  • Hemiclor (chlorthalidone)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + telavancin

    monitor ECG, renal fxn: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • telmisartan
  • Hemiclor (chlorthalidone)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + telmisartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • temsirolimus
  • Hemiclor (chlorthalidone)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + temsirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir alafenamide
  • Hemiclor (chlorthalidone)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tenofovir alafenamide

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tenofovir disoproxil
  • Hemiclor (chlorthalidone)
    +
    tenofovir disoproxil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tenofovir disoproxil

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • terazosin
  • Hemiclor (chlorthalidone)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • terbutaline
  • Hemiclor (chlorthalidone)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + terbutaline

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • teriflunomide
  • Hemiclor (chlorthalidone)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + teriflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • teriparatide
  • Hemiclor (chlorthalidone)
    +
    teriparatide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + teriparatide

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • testosterone
  • Hemiclor (chlorthalidone)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + testosterone

    monitor BP, calcium, especially in cancer pts at incr. risk: combo may incr. risk of hypercalcemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • tetrahydrozoline ophthalmic
  • Hemiclor (chlorthalidone)
    +
    tetrahydrozoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tetrahydrozoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • thalidomide
  • Hemiclor (chlorthalidone)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + thalidomide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thioridazine
  • Hemiclor (chlorthalidone)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Hemiclor (chlorthalidone)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + thiothixene

    monitor BP: combo may incr. risk of hypotension, syncope (additive effects)

  • thyroid
  • Hemiclor (chlorthalidone)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + thyroid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • timolol ophthalmic
  • Hemiclor (chlorthalidone)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tiopronin
  • Hemiclor (chlorthalidone)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tiopronin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tirzepatide
  • Hemiclor (chlorthalidone)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • Hemiclor (chlorthalidone)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tivozanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tizanidine
  • Hemiclor (chlorthalidone)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tobramycin
  • Hemiclor (chlorthalidone)
    +
    tobramycin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tobramycin

    monitor tobramycin levels, renal fxn, electrolytes, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, hypomagnesemia, auditory, vestibular, other adverse effects (additive effects)

  • tobramycin inhaled
  • Hemiclor (chlorthalidone)
    +
    tobramycin inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tobramycin inhaled

    monitor renal fxn, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tolcapone
  • Hemiclor (chlorthalidone)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolmetin
  • Hemiclor (chlorthalidone)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tolmetin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. chlorthalidone efficacy (additive effects; antagonistic effects)

  • topiramate
  • Hemiclor (chlorthalidone)
    +
    topiramate
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + topiramate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • toremifene
  • Hemiclor (chlorthalidone)
    +
    toremifene
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + toremifene

    monitor calcium, especially if tumor flare risk: combo may incr. risk of hypercalcemia (possible additive effects)

  • torsemide
  • Hemiclor (chlorthalidone)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + torsemide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia (additive effects)

  • tramadol
  • Hemiclor (chlorthalidone)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tramadol

    monitor sodium, BP: combo may incr. risk of severe hyponatremia, severe hypotension, including orthostasis, syncope; may decr. chlorthalidone efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • trametinib
  • Hemiclor (chlorthalidone)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + trametinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trandolapril
  • Hemiclor (chlorthalidone)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + trandolapril

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • tranylcypromine
  • Hemiclor (chlorthalidone)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Hemiclor (chlorthalidone)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + trazodone

    monitor sodium, BP: combo may incr. risk of hyponatremia, hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Hemiclor (chlorthalidone)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • triamcinolone
  • Hemiclor (chlorthalidone)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + triamcinolone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • triamterene
  • Hemiclor (chlorthalidone)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + triamterene

    monitor renal function, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • trifluoperazine
  • Hemiclor (chlorthalidone)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Hemiclor (chlorthalidone)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ubrogepant
  • Hemiclor (chlorthalidone)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ubrogepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vaccinia immune globulin
  • Hemiclor (chlorthalidone)
    +
    vaccinia immune globulin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vaccinia immune globulin

    monitor renal fxn; use lowest vaccinia immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • vadadustat
  • Hemiclor (chlorthalidone)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vadadustat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • valacyclovir
  • Hemiclor (chlorthalidone)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + valacyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • valganciclovir
  • Hemiclor (chlorthalidone)
    +
    valganciclovir
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + valganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • valsartan
  • Hemiclor (chlorthalidone)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + valsartan

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • vamorolone
  • Hemiclor (chlorthalidone)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vamorolone

    monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • vancomycin
  • Hemiclor (chlorthalidone)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vancomycin

    VANCOMYCIN IV: monitor renal fxn, vancomycin levels, ototoxicity; VANCOMYCIN PO: consider monitoring renal fxn, vancomycin levels, ototoxicity in pts w/ severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day: combo may incr. vancomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects; incr. oral vancomycin absorption if inflamed or compromised gut mucosa)

  • vandetanib
  • Hemiclor (chlorthalidone)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vandetanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vardenafil
  • Hemiclor (chlorthalidone)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vardenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • vasopressin
  • Hemiclor (chlorthalidone)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vasopressin

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • venlafaxine
  • Hemiclor (chlorthalidone)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + venlafaxine

    monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • vilanterol inhaled
  • Hemiclor (chlorthalidone)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vilanterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • vilazodone
  • Hemiclor (chlorthalidone)
    +
    vilazodone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vilazodone

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • viloxazine
  • Hemiclor (chlorthalidone)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + viloxazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vitamin A (retinol)
  • Hemiclor (chlorthalidone)
    +
    vitamin A (retinol)
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vitamin A (retinol)

    monitor calcium: combo may incr. risk of hypercalcemia (additive effects)

  • voclosporin
  • Hemiclor (chlorthalidone)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + voclosporin

    monitor renal fxn, BP: combo may incr. risk of nephrotoxicity; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • vonoprazan
  • Hemiclor (chlorthalidone)
    +
    vonoprazan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vonoprazan

    monitor magnesium: combo may incr. risk of hypomagnesemia (additive effects)

  • vortioxetine
  • Hemiclor (chlorthalidone)
    +
    vortioxetine
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vortioxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • vosoritide
  • Hemiclor (chlorthalidone)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + vosoritide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • willow bark
  • Hemiclor (chlorthalidone)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + willow bark

    monitor renal fxn, especially w/ high-dose willow bark: combo may incr. risk of renal impairment (additive effects, willow bark may contain salicylates)

  • yohimbe
  • Hemiclor (chlorthalidone)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + yohimbe

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • zavegepant
  • Hemiclor (chlorthalidone)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + zavegepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ziprasidone
  • Hemiclor (chlorthalidone)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ziv-aflibercept
  • Hemiclor (chlorthalidone)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + ziv-aflibercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • zoledronic acid
  • Hemiclor (chlorthalidone)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + zoledronic acid

    monitor renal fxn: combo may incr. zoledronic acid levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • zolmitriptan
  • Hemiclor (chlorthalidone)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + zolmitriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • zonisamide
  • Hemiclor (chlorthalidone)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    chlorthalidone + zonisamide

    monitor renal fxn, potassium: combo may incr. risk of renal impairment, hypokalemia (additive effects)

Caution Advised

  • acitretin
  • Hemiclor (chlorthalidone)
    +
    acitretin
    1 interaction

    Caution Advised

    chlorthalidone + acitretin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • icosapent ethyl
  • Hemiclor (chlorthalidone)
    +
    icosapent ethyl
    1 interaction

    Caution Advised

    chlorthalidone + icosapent ethyl

    caution advised: combo may antagonize antihyperlipidemic effect of omega-3-acid (antagonistic effects)

  • methoxsalen
  • Hemiclor (chlorthalidone)
    +
    methoxsalen
    1 interaction

    Caution Advised

    chlorthalidone + methoxsalen

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • verteporfin
  • Hemiclor (chlorthalidone)
    +
    verteporfin
    1 interaction

    Caution Advised

    chlorthalidone + verteporfin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@49ad93e2
  • hypokalemia, severe
  • electrolyte imbalance
  • arrhythmia
  • pancreatitis
  • cholestatic jaundice
  • anaphylaxis
  • necrotizing angiitis
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • exfoliative dermatitis
  • photosensitivity
  • renal failure
  • interstitial nephritis
  • aplastic anemia
  • agranulocytosis
  • leukopenia
  • hemolytic anemia
  • thrombocytopenia

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@7af8115c
  • hypokalemia
  • hypochloremia
  • hyponatremia
  • hypomagnesemia
  • hypercalcemia
  • hyperuricemia
  • hyperglycemia
  • hyperlipidemia
  • hypotension, orthostatic
  • anorexia
  • nausea
  • vertigo
  • constipation
  • dizziness
  • photosensitivity
  • rash
  • urticaria
  • paresthesia
  • headache
  • muscle spasm
  • weakness
  • impotence

Safety/Monitoring .

Monitoring Parameters
BUN/Cr; electrolytes at baseline, then periodically

Look/Sound-Alike Drug Names
chlorthalidone confused with: chlorothiazide; chlorproMAZINE; clomiPRAMINE

Pregnancy/Lactation .

Pregnancy

Clinical Summary

may use during pregnancy if on chronic tx before conception, otherwise weigh risk/benefit; no known risk of teratogenicity based on human data; possible risk of decr. placental perfusion and neonatal adverse effects, including hypoglycemia, thrombocytopenia, and electrolyte abnormalities, based on limited or conflicting human data; risks not observed if chronic use before conception

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; possible risk of infant harm based on limited human data and drug properties; possible decr. milk production based on conflicting human data

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@6215e912

Metabolism: for chlorthalidone: liver; CYP450: unknown

Excretion: for chlorthalidone: urine 50-75% (primarily unchanged); Half-life: 40-60h

Subclass: Diuretics, Thiazides

Mechanism of Action
for chlorthalidone: inhibits distal convoluted tubule sodium and chloride reabsorption

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: PRM Pharma, LLC

com.epocrates.rxweb.beans.DrugOtherInfoBean@7c242aab

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information